Form 8-K - Current report:
SEC Accession No. 0000950170-25-066952
Filing Date
2025-05-08
Accepted
2025-05-08 16:10:14
Documents
13
Period of Report
2025-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tern-20250508.htm   iXBRL 8-K 49190
2 EX-99.1 tern-ex99_1.htm EX-99.1 112629
3 GRAPHIC img52906712_0.jpg GRAPHIC 6619
  Complete submission text file 0000950170-25-066952.txt   303581

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tern-20250508.xsd EX-101.SCH 26983
15 EXTRACTED XBRL INSTANCE DOCUMENT tern-20250508_htm.xml XML 5119
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39926 | Film No.: 25926139
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)